P53 deletion is not a frequent event in multiple myeloma-Reference-Cited by-同舟云学术

P53 deletion is not a frequent event in multiple myeloma

Published:1999-09 Issue:3 Volume:106 Page:717-719
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Avet-Loiseau Hervé,Li Jian-Yong,Godon Catherine,Morineau Nadine,Daviet Axelle,Harousseau Jean-Luc,Facon Thierry,Bataille Régis

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1999.01615.x/fullpdf

Reference10 articles.

1. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies;Avet-Loiseau;Cancer Research,1998

2. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias;Dohner;Blood,1995

3. Presence of p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy;Drach;Blood,1998

4. Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia;Garcia-Marco;Blood,1996

5. p53, the cellular gatekeeper for growth and division;Levine;Cell,1997

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma;Haematologica;2023-08-03

2. Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma;American Journal of Surgical Pathology;2020-02-28

3. Impact of acquired del(17p) in multiple myeloma;Blood Advances;2019-06-27

4. Complex cytogenetic research of cryptic chromosomal aberrations in patients with multiple myeloma;Russian Journal of Biotherapy;2019-04-19

5. Natural history of multiple myeloma with de novo del(17p);Blood Cancer Journal;2019-03